July 2026’s Global Stock Selections Estimated Below Intrinsic Value

As global markets grapple with fluctuating oil prices and concerns over AI investments, investor sentiment remains cautious, particularly in technology-heavy indices like the Nasdaq Composite. Amid these uncertainties, identifying undervalued stocks can be a strategic approach for investors seeking opportunities that may be trading below their intrinsic value. In this context, understanding key financial metrics and market conditions is crucial to uncovering potential investment gems.
Top 10 Undervalued Stocks Based On Cash Flows
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| VIGO Photonics (WSE:VGO) | PLN484.00 | PLN967.54 | 50% |
| Sahara International Petrochemical (SASE:2310) | SAR13.04 | SAR25.94 | 49.7% |
| Qt Group Oyj (HLSE:QTCOM) | €26.20 | €52.01 | 49.6% |
| JOST Werke (XTRA:JST) | €57.20 | €113.60 | 49.6% |
| Diagnostic Medical Systems (ENXTPA:ALDMS) | €1.06 | €2.10 | 49.5% |
| Chengdu M&S Electronics TechnologyLtd (SHSE:688311) | CN¥20.37 | CN¥40.71 | 50% |
| Casta Diva Group (BIT:CDG) | €3.00 | €6.00 | 50% |
| Cambi (OB:CAMBI) | NOK21.70 | NOK43.26 | 49.8% |
| Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret (IBSE:BRISA) | TRY80.00 | TRY159.27 | 49.8% |
| Alimak Group (OM:ALIG) | SEK126.00 | SEK251.67 | 49.9% |
Here we highlight a subset of our preferred stocks from the screener.
Overview: Ningbo Sanxing Medical Electric Co., Ltd. is engaged in the manufacturing and sale of power distribution products both in China and internationally, with a market cap of CN¥22.56 billion.
Operations: The company’s revenue segments include the production and distribution of power distribution products within China and international markets.
Estimated Discount To Fair Value: 48%
Ningbo Sanxing Medical Electric Ltd. is trading at CN¥17, significantly below its estimated future cash flow value of CN¥32.7, indicating it may be undervalued. Analysts expect its earnings to grow substantially at 54.4% annually, outpacing the broader Chinese market’s growth rate of 25.6%. However, despite strong revenue forecasts and a favorable valuation compared to peers, the company’s profit margins have decreased from last year and its dividend is not well covered by earnings.
Overview: LEM Holding SA, along with its subsidiaries, offers solutions for measuring electrical parameters across various regions including China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America with a market capitalization of CHF529.41 million.
Operations: The company’s revenue segments are not provided in the text.
Estimated Discount To Fair Value: 10.3%
LEM Holding is trading at CHF465, below its estimated future cash flow value of CHF518.56, suggesting it might be undervalued. Despite high debt levels and a volatile share price, earnings are projected to grow significantly at 22.4% annually, surpassing the Swiss market’s growth rate. Recent earnings show substantial improvement with net income rising from CHF1.99 million to CHF9.08 million year-over-year, highlighting strong profitability momentum amidst strategic reviews for long-term value enhancement.
Overview: Temenos AG is a company that develops, markets, and sells integrated banking software systems to financial institutions across various global regions including North America, Europe, the Middle East and Africa, Latin America, and the Asia-Pacific with a market cap of CHF4.70 billion.
Operations: Revenue Segments (in millions of $): Licensing $400, SaaS & Subscription $300, Maintenance $600, and Services $200.
Estimated Discount To Fair Value: 34.2%
Temenos is trading at CHF68.45, below its estimated future cash flow value of CHF104.06, indicating potential undervaluation based on discounted cash flow analysis. Despite high debt levels and recent earnings decline—net income dropped from USD 164.72 million to USD 67.22 million year-over-year—analysts forecast revenue and earnings growth outpacing the Swiss market at 7% and 12.1% per annum respectively, supported by strategic partnerships like those with Sirma Group Holding JSC for business development in new markets.
Key Takeaways
Searching for a Fresh Perspective?
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Ningbo Sanxing Medical ElectricLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com




